CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
0.131
+0.006 (5.04%)
Nov 21, 2024, 11:41 AM EST - Market open
CNS Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 7 | 7 | 3 | 20 | 41 | 65 | |
| Market Cap Growth | -12.42% | 108.14% | -83.67% | -52.32% | -36.70% | - | |
| Enterprise Value | -1 | 6 | -4 | 11 | 40 | 65 | |
| Last Close Price | 0.12 | 63.50 | 120.00 | 1053.60 | 2670.00 | 5925.01 | |
| PB Ratio | 1.23 | -1.50 | 0.39 | 3.18 | 2.95 | 8.55 | |
| P/TBV Ratio | 1.25 | - | 0.39 | 3.18 | 2.95 | 8.55 | |
| Debt / Equity Ratio | 0.01 | -0.07 | 0.05 | 0.06 | 0.03 | - | |
| Quick Ratio | 1.72 | 0.09 | 2.04 | 1.93 | 7.37 | 23.28 | |
| Current Ratio | 1.82 | 0.26 | 2.55 | 2.88 | 8.13 | 25.38 | |
| Return on Equity (ROE) | -2116.75% | -1018.78% | -213.68% | -144.15% | -87.78% | -109.96% | |
| Return on Assets (ROA) | -219.28% | -159.83% | -87.50% | -73.58% | -49.73% | -55.74% | |
| Return on Capital (ROIC) | -1267.40% | -534.54% | -126.44% | -86.48% | -53.75% | -65.02% | |
| Earnings Yield | -278.36% | -282.81% | -476.94% | -73.91% | -23.00% | -5.97% | |
| FCF Yield | -231.43% | -212.19% | -329.81% | -69.06% | -17.84% | -5.50% | |
| Buyback Yield / Dilution | -9861.66% | -176.66% | -55.02% | -58.58% | - | - | |
| Total Shareholder Return | -9861.66% | -176.66% | -55.02% | -58.58% | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.